OrbiMed Advisors »

AgomAb Therapeutics NV shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of AgomAb Therapeutics NV (AGMB) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 193k 12.98

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Eli Lilly & Co. (LLY)
Mbx Biosciences (MBX)
Sinovac Biotech SHS
Astrazeneca Ord (AZN)
Structure Therapeutics Sponsored Ads (GPCR)
Sionna Therapeutics (SION)
Corvus Pharmaceuticals (CRVS)
Arrivent Biopharma (AVBP)
Abivax Sa Sponsored Ads Call Option (ABVX)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Merck & Co (MRK)
Uniqure Nv SHS (QURE)

View all positions for OrbiMed Advisors

Top funds holding AgomAb Therapeutics NV

EQT Fund Management S.a r.l.
Sanofi
Redmile Group
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Nantahala Capital Management
Casdin Capital
Andera Partners
FMR
Standard Life Aberdeen
Samsara BioCapital
Perceptive Advisors
Siren
OrbiMed Advisors

View all funds holding AgomAb Therapeutics NV